On April 30, 2026, the FDA proposed to formally exclude Semaglutide, Tirzepatide, and Liraglutide from the 503B Bulks List, citing no clinical need for outsourcing facilities to compound these drugs from bulk substances
And while Dr Deed welcomed last weeks compounding ban, describing the off-label trend as a sideshow of inappropriate, poorly regulated supply of an injectable medication, he said much more needs to be done
The frequency of the headaches is different from person to person, and sometimes, it directly depends on how you deal with other Ozempic side effects
Once patients with HFpEF are hospitalized for heart failure, their five-year mortality can be as high as 65 percent. While theres now robust evidence that people with HFpEF and obesity can benefit from semaglutide, the expense of the drug can often be a barrier, Shah said